Palatin Technologies Incorporated

Elizabeth G Rowley

Yi-Qun Shi

Gary Olson

Axel Metzger

John H Dodd

Melanocortin receptor-specific compounds of formula I below: wherein the variables are as defined in the specification, and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders.

Growing community of inventors

Kendal Park, NJ, United States of America

Elizabeth G Rowley